Regeneron Pharmaceuticals (NASDAQ:REGN) reported strong financial results for the first quarter of 2026 on Wednesday, April 29, 2026, highlighted by high-double-digit revenue growth and significant regulatory milestones.
Cognizant Technology Solutions (NASDAQ:CTSH) announced its financial results for the first quarter ended March 31, 2026, on Wednesday, April 29, 2026, delivering top-line growth and a significant increase in profitability.
Brinker International (NYSE:EAT) reported financial results for its fiscal third quarter ended March 25, 2026, showcasing the continued strength of its core Chili’s brand in an increasingly competitive casual dining market.
GE HealthCare Technologies (NASDAQ:GEHC) reported financial results for the first quarter ended March 31, 2026, revealing a complex landscape of steady demand offset by operational hurdles and macroeconomic pressures.
Stanley Black & Decker (NYSE:SWK) reported first-quarter 2026 results on Wednesday, April 29, 2026, highlighting a significant transformation of its capital structure.
Avantor (NYSE:AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies industries, reported financial results for the first quarter ended March 31, 2026.
Cognizant (NASDAQ:CTSH) announced on Wednesday, April 29, 2026, that it has agreed to acquire Astreya, a leading provider of platform-led, AI-first managed services, for approximately $600 million.
Clarivate (NYSE:CLVT), a global leader in providing trusted intelligence to accelerate the pace of innovation, reported financial results for the first quarter ended March 31, 2026, on Wednesday, April 29, 2026.
Lithia & Driveway (NYSE:LAD) reported record-breaking revenue for the first quarter of 2026, as the automotive retailer leveraged its massive scale and growing captive finance arm to navigate a complex consumer environment.
Shanghai Henlius Biotech and Organon (NYSE:OGN) announced on Wednesday, April 29, 2026, that the European Commission (EC) has granted marketing authorization for POHERDY (pertuzumab), making it the first and only approved biosimilar to the reference product PERJETA in Europe.
Yum China Holdings (NYSE:YUMC), the largest restaurant company in China, reported financial results for the first quarter ended March 31, 2026, showcasing a strategy of aggressive physical expansion and digital dominance.
UBS Group (NYSE:UBS) reported a surge in first-quarter profitability on Wednesday, April 29, 2026, as the banking giant nears the final stages of its historic integration of Credit Suisse.
-640x360.webp&w=3840&q=75)
